Program Overview
The Hematology/Oncology Residency at Stanford Health Care is a PGY-2
specialty training program that offers extensive hematology and
oncology experiences at Stanford Comprehensive Cancer Center,
currently ranked top 10 in the nation. One applicant is accepted per year.
The program is designed to transition PGY-1 residency graduates from
general practice to specialized practice focused on the care of
patients with oncologic and/or hematologic disorders. Residency
graduates will be equipped to participate as integral members of
interdisciplinary teams, assuming responsibility for pharmaceutical care.
Throughout the program, the resident will gain practical experience
in the management in neoplastic diseases as well as cancer-related and
cancer treatment-related disorders. Due to the prominent use of
investigational drugs in the treatment of cancer, the resident will
also gain the knowledge and skills necessary to practice effectively
in clinical research environments. They will be able to manage the
preparation, distribution, and disposal of hazardous medications in
both inpatient and ambulatory settings. Their experience will also
include leadership in formulary decision-making for cancer-related medications.
Groomed for practice leadership, the PGY-2 Hematology/Oncology
resident will be able to successfully serve health-care organizations
with the clinical and practice skills necessary for effective
decision-making in the treatment of oncologic and hematologic disorders.
Program Goals
The goal of the PGY-2 Hematology/Oncology Residency Program is to
provide a broad experience-based foundation in hematology/oncology, to
develop his/her clinical skills, and to prepare for a comprehensive
clinical practice in hematology/oncology.
Program Structure
The Hematology/Oncology Specialty Residency is accredited by the
American Society of Health System Pharmacists (ASHP). The program
follows the ASHP Residency Learning System (RLS) and its goals and
learning objectives are consistent with standards developed by ASHP.
Required Program Activities
- Orientation/Training – 1-2 weeks
- Inpatient Oncology –
4-6 weeks
- Inpatient Hematology – 4-6 weeks
- Inpatient
Blood and Marrow Transplantation (BMT) – 4 weeks
- Outpatient
Hematology/Oncology/BMT Clinics – 12 weeks and longitudinal
- Research Project – longitudinal
- Chemotherapy
Preparation and Dispensing – longitudinal
Elective Rotations
- Pediatric Hematology/Oncology/BMT
- Off-site
Hematology/Oncology/BMT Services*
- Inpatient Infectious
Disease
- Palliative/Hospice Care
- Pain Service
- Hematology Consults
- Oncology Consults
* A maximum of one off-site rotation will be permitted.
Specialized Residency Requirement
- Complete and present a research project at the Western States
Conference and/or HOPA annual meeting.
- Participate in
teaching activities with PGY1 residents and pharmacy students
- Prepare and present drug monograph for the Pharmacy &
Therapeutics Committee
- Staff minimum 16 hours every 4
weeks
- Attend hematology/oncology related committee meetings
and teaching sessions
Preceptors
Eun-Jeong Kim, PharmD, MS, BCPS, BCOP received her degree from
the University of Florida in 2003. She completed her pharmacy practice
residency at Shands Jacksonville/The University of Florida Academic
Health Center and PGY2 oncology pharmacy residency at University of
Washington Medical Center. She worked as a clinical oncology
pharmacist at Hematology/Oncology Ambulatory Clinic at Kaiser
Permanente and Sutter Health for seven years before joining the
hematology/oncology specialty area at Stanford Hospital &
Clinics.
Alice Chang, Pharm.D. received her degree from the University
of Colorado in 1998. She completed an ambulatory care residency at
University of Illinois at Chicago and worked at Olive-View UCLA
Medical Center for 4 years before joining Stanford Hospital &
Clinics in 2003. She is currently practicing as a clinical oncology
pharmacist in the outpatient Cancer Center.
Ya-Hwei Cheng, MS, Pharm.D. received her MS in health system
management from Union University, NY and pharmacy degree. from
University of Florida. She joined Stanford Hospital & Clinics in
1997. She has practiced in medicine, critical care, cardiology,
orthopedics, pediatrics, oncology and investigational drug services.
She is currently a clinical pharmacist specializing in BMT.
Magdalena Seyer, Pharm.D., BCPS received her degree from the
University of California, San Francisco in 2006. She completed a
pharmacy practice residency at Stanford Hospital & Clinics. She
worked as a clinical pharmacist for 2 years before transitioning into
hematology and oncology at Stanford Hospital & Clinics.
Latanya Dean, Pharm.D., BCOP (Manager) received her
degree from the University of Washington in 2001. She completed a
general practice residency at Stanford Hospital & Clinics in June
2002. After residency she accepted a clinical position at SHC
and worked in the Cancer Center as a Clinical Pharmacist, then as a
Lead Pharmacist overseeing the inpatient and outpatient oncology
pharmacy services. Currently Latanya is the manager of oncology
pharmacy services.
Michelle Ho, Pharm.D., BCOP received her degree from University
of the Pacific in 2008. She completed her pharmacy practice residency
and PGY2 hematology/oncology pharmacy residency at Stanford Hospital
& Clinics. Upon the completion of her PGY2 residency in 2010, she
accepted a position at SHC as a clinical pharmacist specializing in
hematology and oncology.
Ann Le, Pharm.D., BCPS received her degree from the
University of California, San Francisco in 2009. She completed a
pharmacy practice residency at University of California, San Diego.
She completed a hematology/oncology residency at Stanford Hospital
& Clinics in 2010 currently works as a clinical pharmacist
specializing in hematology and oncology.
Fu-ying Lee-Lam, R.Ph. received her B.S from St. John’s
University, New York in 1988. She worked at Memorial Sloan Kettering
for five years before moving to California. Currently she works at
Stanford Health Care as a Bone Marrow Transplant pharmacist. BMT has
been her focus of practice for the last 15 years.
Samit Patel, Pharm.D., BCOP graduated from the University of
Houston in 2007. He completed his pharmacy practice residency at
Presbyterian Hospital of Dallas/Texas Tech University Health Science
Center. He completed a hematology/oncology residency at Stanford
Hospital & Clinics and currently works as a clinical pharmacist in hematology/oncology.
Faye Tsung, Pharm.D. (Lead Pharmacist) received her Bachelors
in Pharmacy at the University of Toronto in 1989. In 1990, she
completed an Industrial Pharmacy Residency at Eli Lilly Canada Inc. In
1994 she received her Doctor of Pharmacy degree at Philadelphia
College of Pharmacy and Science. The following year she completed an
oncology residency at the University of Illinois at Chicago. She
joined Stanford Hospital & Clinics in 2002 and currently works as
a Lead Pharmacist overseeing the inpatient and outpatient oncology
pharmacy services.
Ann Vongspanich, Pharm.D. received her BS degree in Biology at
Santa Clara University then obtained her pharmacy degree at the
University of the Pacific. She completed her pharmacy practice
residency at Stanford Hospital & Clinics in 2005. She currently
works in the ambulatory care anticoagulation clinic and cancer center pharmacy.
Joanna Wang, Pharm.D. received her undergraduate degree in
Biology from the University of California, Irvine and her Doctor of
Pharmacy degree from the University of Southern California in
1991. She completed her residency at University of California, Los
Angeles in 1992 and currently works as a clinical pharmacist in Bone
Marrow Transplant & Oncology.
Abraham Chang, Pharm.D graduated from the University of the
Pacific in 2012. He completed his PGY-1 pharmacy practice residency in
2014 and PGY-2 hematology/oncology residency at Stanford in 2015. He
currently works as a clinical pharmacist in hematology/oncology.
Ellen Wong, Pharm.D., BCOP received her degree from the
University of California, San Francisco in 2009. She completed a
pharmacy practice residency at University of California, Davis. She
worked a hematology/oncology clinical pharmacist at UC Davis Medical
Center for 3 years before joining the hematology/oncology specialty
area at Stanford Healthcare.
Linh Tran, Pharm.D. earned her degree from Western University
of Health Sciences in 2012. She completed a general pharmacy practice
residency at Baptist Memorial Hospital in Memphis, TN in 2013 and a
hematology/oncology residency at Stanford Hospital and Clinics in
2014. Currently, she works as a clinical pharmacist specializing in
hematology and oncology.
John Hui, Pharm.D., BCPS, BCOP received his Bachelor of
Pharmacy degree from the Chinese University of Hong Kong in 2002 and
his Doctor of Pharmacy degree from North Dakota State University in
2006. He completed a PGY1 pharmacy practice residency at Detroit
Medical Centers in 2007 and a PGY2 hematology/oncology pharmacy
residency at Roswell Park Cancer Institute at Buffalo, New York in
2010. Upon the completion of PGY2 residency, he worked at University
of Miami Sylvester Comprehensive Cancer Center as a Bone Marrow
Transplant clinical pharmacist specialist. In 2015, he accepted a
position at Stanford Health Care as a clinical pharmacist specializing
in hematology and oncology.
Huyen Tran, PharmD, BCOP received her degree from the
University of California San Francisco in 2009. She completed her
pharmacy practice residency at Stanford Health Care and PGY2 oncology
pharmacy residency at The University of Texas MD Anderson Cancer
Center. She worked as a clinical oncology pharmacist at UT MD Anderson
for 4 years before joining the hematology/oncology specialty service
at Stanford Health Care.
Postgraduate Year Two (PGY2) Pharmacy Stanford Resident: 2015 – 2016